BMC Public Health 2008, 8:149 http://www.biomedcentral.com/1471-2458/8/149 tistical analyses. Finally, thanks go to the external reviewers of this paper; Elizabeth Katz, James Sorensen and Mary-Lynn Brecht. References 1. World Health Organization: The Global Burden. [http:// www.who.int/substance_abuse/facts/global_burden/en/index.html]. 2. Home Office Drugs Strategy Directorate: Updated Drug Strategy 2002. London, Home Office Drugs Strategy Directorate; 2002. 3. Department of Health: Tackling Drugs to Build a Better Britain. The Government's Ten-Year Strategy for Tackling Drugs Misuse. London, Stationery Office; 1998. 4. National Treatment Agency for Substance Misuse: Business Plan. London, National Treatment Agency for Substance Misuse ; 2006. 5. National Treatment Agency for Substance Misuse: Statistics for drug treatment activity in England 2006/07. National Drug Treatment Monitoring System. [http://www.nta.nhs.uk/media/ media_releases/2007_media_releases/ statistics_for_drug_treatment_activity_in_england_2006_07_statistic al_release_181007.aspx]. 6. Gossop M, Marsden J, Stewart D, Rolfe A: Treatment retention and 1 year outcomes for residential programmes in England. Drug and Alcohol Dependence 1999, 57:89-98. 7. Simpson DD, Joe GW, Rowan-Szal GA, Greener JM: Drug abuse treatment process components that improve retention. Jour- nal of Substance Abuse Treatment 1997, 14:565-572. 8. Hser YI, Joshi V, Anglin MD, Fletcher B: Predicting posttreatment cocaine abstinence for first-time admissions and treatment repeaters. American Journal of Public Health 1999, 89:666-671. 9. Joe GW, Simpson DD, Dansereau DF, Rowan-Szal GA: Relationship between counselling rapport and drug abuse treatment out- comes. Psychiatric Services 2001, 52:1223-1229. 10. Hser YI, Evans E, Huang D, Anglin MD: Relationship between drug treatment services, retention, and outcomes. Psychiatric Serv- ices 2004, 55:767-774. 11. National Treatment Agency for Substance Misuse: Towards treat- ment effectiveness. London, National Treatment Agency for Sub- stance Misuse; 2007. 12. National Treatment Agency for Substance Misuse: Improving treat- ment effectiveness through improvements in early retention - the measurement of attrition. London, National Treatment Agency for Substance Misuse ; 2005. 13. Hser YI, Joshi V, Maglione M, Chou CP, Anglin MD: Effects of pro- gram and patient characteristics on retention of drug treat- ment patients. Evaluation and Program Planning 2001, 24:331-341. 14. Beynon C, Bellis MA, Millar T, Meier P, Thomson R, Mackway-Jones K: Hidden need for drug treatment services: measuring problematic drug use in the North West of England. Journal of Public Health Medicine 2001, 21:286-291. 15. National Treatment Agency for Substance Misuse: Statistics for drug treatment activity in England 2005/06 from the National Drug Treatment Monitoring System. [http:// www.nta.nhs.uk/]. 16. National Treatment Agency for Substance Misuse: Models of Care for Substance Misuse. London, National Treatment Agency for Substance Misuse; 2002. 17. Office of the Deputy Prime Minister: The English Indices of Dep- rivation 2004: Summary (revised). London , Office of the Dep- uty Prime Minister. 18. Beynon CM, Bellis MA, McVeigh J: Trends in drop out, drug free discharge and rates of representation: a retrospective cohort study of drug treatment clients in the North West of England. BMC Public Health 2006, 6:205-213. 19. Hills M, De Stavola BL: A short introduction to STATA 8 for biostatistics. London, Timberlake Consultants Ltd.; 2003. 20. Office of National Statistics: KS06 Ethnic group. [http://www.sta tistics.gov.uk/statbase/Expodata/Spreadsheets/D6561.xls]. 21. National Treatment Agency for Substance Misuse: Black and minority ethnic communities in England: a review of the lit- erature on drug use and related service provision. London, National Treatment Agency for Substance Misuse; 2003. 22. Patel K, Wibberley C: Young Asians and drug use. Journal of Child Health Care 2002, 6:51-59. 23. Finn P: Addressing the needs of cultural minorities in drug treatment. Journal of Substance Abuse Treatment 1994, 11:325-337. 24. Ellis M: Support for the effectiveness of culturally competent drug and alcohol treatment, policy planning and programme development. Journal of Substance Use 1999, 4:35-40. 25. Rhoades HM, Creson D, Elk R, Schmitz J, Grabowski J: Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. American Journal of Public Health 1998, 88:34-39. 26. Wood J, Hennell T, Jones A, Hooper J, Tocque K, Bellis MA: Where wealth means health: illustrating inequality in the North West. Liverpool, North West Public Health Observatory; 2006. 27. Ridenour TA, Cottler LB, Compton WM, Spitznagle EL, Cunningham- Williams RM: Is there a progression from abuse disorders to dependence disorders? Addiction 2003, 98:635-644. 28. Beardsley K, Wish ED, Fitzelle DB, O'Grady K, Arria AM: Distance travelled to outpatient drug treatment and client retention. Journal of Substance Abuse Treatment 2003, 25:279-285. 29. National Drug Evidence Centre: Treatment effectiveness: dem- onstration analysis of treatment surveillance data about treatment completion and retention. London, National Treat- ment Agency for Substance Misuse; 2004. 30. Gossop M, Marsden J, Stewart D, Kidd T: The National Treat- ment Outcome Research Study (NTORS): 4-5 year follow- up results. Addiction 2003, 98:291-303. 31. Gossop M, Stewart D, Treacy S, Marsden J: A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction 2002, 97:39-47. 32. Coffin PO, Galea S, Ahern J, Leon AC, Vlahov D, Tardiff K: Opiates, cocaine and alcohol combinations in accidental drug over- dose deaths in New York City, 1990 - 98. Addiction 2003, 98:739-747. 33. Health Protection Agency, Health Protection Scotland, National Pub- lic Health Service for Wales, CDSC Northern Ireland, CRDHB, and the UASSG: Shooting Up: Infections among injecting drug users in the United Kingdom 2005. London, Health Protection Agency; 2006. 34. Khundakar A, Morleo M, Khundakar K, Marr A, McVeigh J, Bellis MA: Individuals stating alcohol as a secondary or tertiary prob- lematic substance in contact with treatment services in the North West during 2006/07. Liverpool, Liverpool John Moores University; 2007. 35. Solomon E, Rutherford M: Community Sentences Digest. Lon- don, Kings College; 2007. 36. Scott CK, Foss MA, Dennis ML: Pathways in the relapse--treat- ment--recovery cycle over 3 years. Journal of Substance Abuse Treatment 2005, 28(2 Suppl 1):S63-S72. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2458/8/149/pre pub Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime." Sir Paul Nurse, Cancer Research UK Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp BioMedcentral Page 11 of 11 (page number not for citation purposes)